Category
Facing a Good Manufacturing Practice (GMP) audit can be a high-stakes event for any pharmaceutical, biotech, or medical device company. A negative finding can lead to production delays, costly remediation,…
As life sciences companies increasingly adopt AI, the question of regulatory compliance looms large. Can these powerful, often "black box," systems align with the stringent requirements of FDA 21 CFR…
Facing your first FDA inspection for in vitro diagnostics can be daunting. This comprehensive guide provides the essential framework for success, covering everything from pre-inspection readiness and building a robust…
In today's complex regulatory landscape, manual compliance is no longer enough. The risk of human error, costly delays, and FDA scrutiny is too high. This guide explores the transformative power…
The regulatory landscape for pharmaceuticals is constantly evolving. As we move into 2025, the FDA is adapting its strategies to address new technologies and global challenges. This guide explores the…
Navigating a pre-approval inspection for biologics is the final, critical hurdle before commercialization. This pivotal assessment by the FDA determines if your manufacturing processes, facilities, and quality systems can consistently…
Navigating the new cosmetic labeling FDA requirements for 2025 is critical for market success and avoiding regulatory action. With the full implementation of the Modernization of Cosmetics Regulation Act (MoCRA),…
In the highly regulated medical device industry, GxP compliance is not just a best practice—it is a fundamental requirement for market access and patient safety. With regulatory scrutiny intensifying in…
Are you prepared for FDA audits for cosmetic manufacturers? With the new MoCRA regulations, the FDA has enhanced authority to inspect facilities and enforce compliance. This guide covers the essentials…
Discover the essentials of Good Distribution Practice (GDP) for the biologics supply chain in our comprehensive 2025 guide. This article explores the critical challenges of maintaining GDP compliance in biologics…
Sign in to access member resources, inspection tools and training.
New here? Create an account
